Nazim Vekilov
General Manager at EGIS Pharmaceuticals PLC, Azerbaijan
"Everybody is aware that Egis is looking out for its people. We are coaching them, we’re trying our best to make them feel comfortable."
"Everybody is aware that Egis is looking out for its people. We are coaching them, we’re trying our best to make them feel comfortable."
Mrs. Júlia Kovács Dancsok
Head of analytical documentation department of finished products
"There are several reasons why it's worth choosing Egis. For me, the atmosphere and the friendly, calm and harmonious workplace relationships are priceless. Teams and departments work together in full cooperation to perform serious jobs—and Egis provides the backdrop we need."
"There are several reasons why it's worth choosing Egis. For me, the atmosphere and the friendly, calm and harmonious workplace relationships are priceless. Teams and departments work together in full cooperation to perform serious jobs—and Egis provides the backdrop we need."
Attila Szabó
Active substance production associate
"Everything is exciting about my current job. We got a brand new plant that presented new challenges for us. None of us has ever worked at a plant like this before, not even at Egis. It really united the members of our team."
"Everything is exciting about my current job. We got a brand new plant that presented new challenges for us. None of us has ever worked at a plant like this before, not even at Egis. It really united the members of our team."
Arina Gholmieh
General Manager at EGIS Pharmaceutical PLC, Romania
"I think it’s the most important asset of the company – the people."
"I think it’s the most important asset of the company – the people."
Albert Magyari
HP product development section leader
"I would highlight the employee-focused approach of Egis, and that we are given all the help expected of a workplace—with a good atmosphere for product development."
"I would highlight the employee-focused approach of Egis, and that we are given all the help expected of a workplace—with a good atmosphere for product development."
Our Mission
During the more than 100 years since its establishment, Egis has become a leading generic pharmaceutical company in the Central Eastern European region. The composition of our corporate management demonstrates our activities, which extend to every field of the pharmaceutical value chain: from research and development, through production to sales and marketing. Our success is the result of the joint effort of our 4,400 colleagues. Thanks to them, we are able to contribute to the treatment of approximately 30 million patients around the world each year.

Who we are?

We are one of the leading generic pharmaceutical companies in Central Eastern Europe, and our activities incorporate all areas of the pharmaceutical value chain. Egis is a member of the Servier Group, an international pharmaceutical company governed by a non-profit foundation with its headquarters in France.

Our products range from active ingredients, through tablets and injections, to galenic (i.e. liquid and semi-solid) formulations and are available in 71 countries through our network of subsidiaries and representative offices or partners. Last financial year our portfolio consisted of 647 products that belonged to 164 product lines and contained 150 active ingredients.

Our main focus lies on treating diseases of the cardiovascular and central nervous systems; however, we also provide modern treatment solutions in the fields of oncology and women’s health. In 2013, we launched our first biosimilar monoclonal antibody product. This was also the first biosimilar monoclonal antibody (mAb) in the European Union. Since then we launched three additional  biosimilar drugs.

As one of the companies in the Central Eastern European region firmly committed to innovation, we devote approximately EUR 50 million yearly to R&D. Our research and development activities focus on high-quality, value-added branded generic products.

Submit
Submit

Add this position to job cart

You will be able to find it later easily